Shunichi Kitajima

Part of Trans Genic Inc., Primmune Inc is a Japanese company that manufactures and markets pharmaceutical ingredients. The company is based in Kobe, Japan. Primmune was acquired by Trans Genic Inc. on May 15, 2006 for $2.15 million.

Skylight Biotech, Inc. provides software products and services to medical professionals. It also provides laboratory services for lipoprotein, subclass determination for clinical and research use with proprietary HPLC-based systems. The company was founded on August 28, 2002 and is headquartered in Akita, Japan.

MCosmetics KK is a private company based in Tokyo, Japan that specializes in manufacturing and distributing cosmetics. The Japanese company was acquired by MCosmetics KK/Egawa/ from Immuno-Biological Laboratories Co., Ltd. on March 31, 2015 for $0.17 million.

TG Business Service Inc. engages in business succession, advise and support services relating to rehabilitation, and merger and acquisitions. The company was founded on November 15, 2017 and is headquartered in Fukuoka, Japan.

Bloom Technology Corp. provides pharmaceutical, raw cell preservation technology, and veterinary drug research and development services. The company is based in Kumamoto, Japan. The Japanese company was founded in 2014 by Hideki Saito.

Part of Trans Genic Inc., Medicinal Chemistry Pharmaceutical Co. Ltd. develops antibody drugs for controlling diseases using glycol technology. The company is based in Sapporo, Japan. The Japanese company was founded in 2010 by Katsuhiko Ito. Medicinal Chemistry Pharmaceutical Co. was acquired by Trans Genic Inc. on April 22, 2020.

Galax Corp. imports, wholesales, and retails porcelain, china, silverware, crystalware, kitchen items, and household goods. The company was founded on September 12, 1984 and is headquartered in Tokyo, Japan.

Medicinal Chemistry Pharmaceuticals Co. Ltd. is a company based in Sapporo, Japan that was founded in 2010. The Japanese company specializes in providing a monoclonal antibody-produced service made by ganp® mouse technology, which is expected to acquire high-parental and high-specific antibodies. The company offers antibody variable areas analysis, hybridoma culture, antibody refinement by affinity column chromatography, and contract services for various refined antibodies. Additionally, they provide analysis services for variable regional sequences for mouse monoclonal antibodies. The company also accepts various consultations on sugar chain synthesis and sugar chain analysis. The company's main focus is on podoplanin (PDPN), a mucin type that highly reflects on various malignant tumors such as brain tumors, oral cancer, lung cancer, esophageal cancer, malignant mild skin, ovarian cancer, cervical cancer, etc. PDPN has been revealed to enhance the infiltration and metastasis of cancer cells, and is related to cancer.